Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis (Q36715777)
Jump to navigation
Jump to search
scientific article published on February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis |
scientific article published on February 2007 |
Statements
1 reference
Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis (English)
1 reference
John V Heymach
1 reference
Roy S Herbst
1 reference
Amir Onn
1 reference
Michael S O'Reilly
1 reference
Anderson J Ryan
1 reference
1 February 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference